Search research articles
Contact Us
Filters
Showing results (91-100 of 126) with videos related to
Page
of 13
Sort By:
British Journal of Haematology
|
October 20, 2010
A randomized phase II trial of Arginine Butyrate with standard local therapy in refractory sickle cell leg ulcers
Lillian McMahon, Hannah Tamary, Melissa Askin, et al.
Journal of Clinical Pharmacology
|
March 23, 2011
Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers
Susan P Perrine, William A Wargin, Michael S Boosalis, et al.
Haematologica
|
December 7, 2022
Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes
Joshua F Zeidner, Flora Mazerolle, Jonathan Norton, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
December 15, 2010
A vitamin D receptor-alkylating derivative of 1α,25-dihydroxyvitamin D3 inhibits growth of human kidney cancer cells and suppresses tumor growth
James R Lambert, Vikram J Eddy, Christian D Young, et al.
Vaccine
|
February 21, 2026
Safe and durable immune responses to a single dose DNA COVID-19 vaccine in previously vaccinated or SARS-CoV-2-infected adults: A phase 1 study
Khursheed Anwer, Lauren Musso, Ninaad Lasrado, et al.
Anticancer Research
|
July 25, 2008
Prostate 25-hydroxyvitamin D-1alpha-hydroxylase is up-regulated by suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor
Lilin Wang, Kelly S Persons, Dan Jamieson, et al.
Clinical and Translational Science
|
January 27, 2021
Asia-inclusive global development of pevonedistat: Clinical pharmacology and translational research enabling a phase 3 multiregional clinical trial
Xiaofei Zhou, Sharon Friedlander, Erik Kupperman, et al.
Clinical Pharmacology in Drug Development
|
November 16, 2022
Effect of Pevonedistat, an Investigational NEDD8-Activating Enzyme Inhibitor, on the QTc Interval in Patients With Advanced Solid Tumors
Xiaofei Zhou, Debra L Richardson, Afshin Dowlati, et al.
Bioresearch Open Access
|
August 3, 2018
A New Approach to Treating Neurodegenerative Otologic Disorders
Walter H Moos, Douglas V Faller, Ioannis P Glavas, et al.
Bioresearch Open Access
|
January 2, 2018
Epigenetic Treatment of Neurodegenerative Ophthalmic Disorders: An Eye Toward the Future
Walter H Moos, Douglas V Faller, Ioannis P Glavas, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 126) with videos related to
Sort By:
Page
of 13
British Journal of Haematology
|
October 20, 2010
A randomized phase II trial of Arginine Butyrate with standard local therapy in refractory sickle cell leg ulcers
Lillian McMahon, Hannah Tamary, Melissa Askin, et al.
Journal of Clinical Pharmacology
|
March 23, 2011
Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers
Susan P Perrine, William A Wargin, Michael S Boosalis, et al.
Haematologica
|
December 7, 2022
Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes
Joshua F Zeidner, Flora Mazerolle, Jonathan Norton, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
December 15, 2010
A vitamin D receptor-alkylating derivative of 1α,25-dihydroxyvitamin D3 inhibits growth of human kidney cancer cells and suppresses tumor growth
James R Lambert, Vikram J Eddy, Christian D Young, et al.
Vaccine
|
February 21, 2026
Safe and durable immune responses to a single dose DNA COVID-19 vaccine in previously vaccinated or SARS-CoV-2-infected adults: A phase 1 study
Khursheed Anwer, Lauren Musso, Ninaad Lasrado, et al.
Anticancer Research
|
July 25, 2008
Prostate 25-hydroxyvitamin D-1alpha-hydroxylase is up-regulated by suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor
Lilin Wang, Kelly S Persons, Dan Jamieson, et al.
Clinical and Translational Science
|
January 27, 2021
Asia-inclusive global development of pevonedistat: Clinical pharmacology and translational research enabling a phase 3 multiregional clinical trial
Xiaofei Zhou, Sharon Friedlander, Erik Kupperman, et al.
Clinical Pharmacology in Drug Development
|
November 16, 2022
Effect of Pevonedistat, an Investigational NEDD8-Activating Enzyme Inhibitor, on the QTc Interval in Patients With Advanced Solid Tumors
Xiaofei Zhou, Debra L Richardson, Afshin Dowlati, et al.
Bioresearch Open Access
|
August 3, 2018
A New Approach to Treating Neurodegenerative Otologic Disorders
Walter H Moos, Douglas V Faller, Ioannis P Glavas, et al.
Bioresearch Open Access
|
January 2, 2018
Epigenetic Treatment of Neurodegenerative Ophthalmic Disorders: An Eye Toward the Future
Walter H Moos, Douglas V Faller, Ioannis P Glavas, et al.
Page
of 13